Rheumatoid arthritis (RA) is a chronic, debilitating autoimmune disorder involving
inflammation and progressive destruction of the joints, affecting up to 1% of the population …

Understanding of the causes and underlying mechanisms of pain in people with RA is
rapidly changing. With the advent of more effective disease modifying drugs, joint …

Objective To identify a core set of domains (outcomes) to be measured in psoriatic arthritis
(PsA) clinical trials that represent both patients' and physicians' priorities. Methods We …

We have recently highlighted (and added to) the considerable evidence that blood can
contain dormant bacteria. By definition, such bacteria may be resuscitated (and thus …

Hintergrund: Medikamentöse Therapiestrategien zur Behandlung der rheumatoiden Arthritis
sind entscheidend für den Langzeitverlauf. Sie dienen dem Ziel, durch frühe und …

Current guidelines for the management of rheumatoid arthritis (RA) recommend early
treatment and a treat-to-target goal of remission or low disease activity. Over the past …

Although clinical outcomes for patients with rheumatoid arthritis (RA) have greatly improved
with the use of biologic and conventional DMARDs, approximately 40% of patients do not …

Patient reported outcomes (PRO) are at the core of assessing RA treatment response with
patient assessments of global health or disease activity, pain, and physical function included …

The goals in the management of established rheumatoid arthritis (RA) are to control pain
and disease activity, prevent further joint damage, and enhance functioning and quality of …

Zusammenfassung Hintergrund Medikamentöse Therapiestrategien zur Behandlung der
rheumatoiden Arthritis sind entscheidend für den Langzeitverlauf. Sie dienen dem Ziel …